Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Change in Accured Expenses (2016 - 2025)

Ingevity (NGVT) has disclosed Change in Accured Expenses for 11 consecutive years, with $9.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses fell 6.12% to $9.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$8.1 million, a 5.81% increase, with the full-year FY2024 number at -$1.0 million, up 87.01% from a year prior.
  • Change in Accured Expenses was $9.2 million for Q3 2025 at Ingevity, up from -$9.8 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $17.3 million in Q3 2022 to a low of -$20.6 million in Q2 2022.
  • A 5-year average of -$110526.3 and a median of $800000.0 in 2022 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: soared 493.18% in 2022, then tumbled 2187.5% in 2023.
  • Ingevity's Change in Accured Expenses stood at $5.0 million in 2021, then crashed by 84.0% to $800000.0 in 2022, then crashed by 2187.5% to -$16.7 million in 2023, then surged by 45.51% to -$9.1 million in 2024, then surged by 201.1% to $9.2 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Change in Accured Expenses are $9.2 million (Q3 2025), -$9.8 million (Q2 2025), and $1.6 million (Q1 2025).